Merck Receives 2015 ENERGY STAR Sustained Excellence Award from U.S. Environmental Protection Agency


April 6, 2015 7:00 am ET

Company Receives EPA Honor for 10th Consecutive Year

Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that it has received an ENERGY STAR 2015 Partner of the
Year – Sustained Excellence Award from the U.S. Environmental Protection
Agency (EPA) for its continued improvement of energy performance and
leadership in energy management in both the pharmaceutical and
industrial sectors.

Merck has been an ENERGY STAR partner since 1995 and recognized by the
EPA for 10 consecutive years, two times as Partner of the Year and now
an eighth time for Sustained Excellence.

“Merck’s philosophy of being a responsible corporate citizen includes
ensuring we manage our energy use efficiently,” said Rodney Freeman,
vice president, global workplace & enterprise services, Merck. “Our
partnership with ENERGY STAR helps us focus on our main goal of reducing
energy consumption, and we are proud that we are using greener sources
of energy and reducing greenhouse gas emissions.”

The award recognizes four Merck manufacturing sites that have achieved
ENERGY STAR rankings in the top 25 percent of pharmaceutical plant
energy performance nationwide: Arecibo, Puerto Rico; Cleveland, Tenn.;
Las Piedras, Puerto Rico; and Elkhorn, Neb.

Also achieving certification this year were office buildings in
Whitehouse Station, N.J., as well as office buildings in Upper Gwynedd,
Pa. and West Point, Pa.

Additionally, three sites were recognized for meeting the ENERGY STAR
Challenge for Industry by reducing their energy intensity by 10 percent
over a five-year period. The sites recognized are Barceloneta, Puerto
Rico; Friesoythe, Germany; and LaValle, France.

“Through their sustained participation with ENERGY STAR, Merck is
helping Americans save money, save energy and do their part to reduce
our nation’s greenhouse gas emissions that fuel climate change,” said
EPA Administrator Gina McCarthy. “I applaud Merck for earning EPA’s
highest ENERGY STAR award, the 2015 Partner of the Year – Sustained
Excellence Award, demonstrating a strong commitment to energy efficiency
and to preserving a healthy planet for future generations.”

For more information about Merck’s ongoing environmental and energy
conservation efforts, please visit


ENERGY STAR is the simple choice for energy efficiency. For more than 20
years, people across America have looked to EPA’s ENERGY STAR program
for guidance on how to save energy, save money, and protect the
environment. Behind each blue label is a product, building, or home that
is independently certified to use less energy and cause fewer of the
emissions that contribute to climate change. Today, ENERGY STAR is the
most widely recognized symbol for energy efficiency in the world,
helping families and businesses save $300 billion on utility bills,
while reducing greenhouse gas emissions by two billion metric tons since
1992. Join the millions who are already making a difference at

About Merck

Today’s Merck is a global health care leader working to help the world
be well. Merck is known as MSD outside the United States and Canada.
Through our prescription medicines, vaccines, biologic therapies and
animal health products, we work with customers and operate in more than
140 countries to deliver innovative health solutions. We also
demonstrate our commitment to increasing access to health care through
far-reaching policies, programs and partnerships. For more information,
and connect with us on Twitter,
and YouTube.

Forward-Looking Statement

This news release includes “forward-looking statements” within the
meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These statements are based upon the
current beliefs and expectations of Merck’s management and are subject
to significant risks and uncertainties. If underlying assumptions prove
inaccurate or risks or uncertainties materialize, actual results may
differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry
conditions and competition; general economic factors, including interest
rate and currency exchange rate fluctuations; the impact of
pharmaceutical industry regulation and health care legislation in the
United States and internationally; global trends toward health care cost
containment; technological advances, new products and patents attained
by competitors; challenges inherent in new product development,
including obtaining regulatory approval; Merck’s ability to accurately
predict future market conditions; manufacturing difficulties or delays;
financial instability of international economies and sovereign risk;
dependence on the effectiveness of Merck’s patents and other protections
for innovative products; and the exposure to litigation, including
patent litigation, and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Additional factors that could cause results to differ
materially from those described in the forward-looking statements can be
found in Merck’s 2014 Annual Report on Form 10-K and the company’s other
filings with the Securities and Exchange Commission (SEC) available at
the SEC’s Internet site (

Claire Gillespie, 267-305-0932
Justin Holko, 908-740-1879

Unsubscribe from email alerts